THE POSSIBLE USE OF SERUM MHC CLASS-II LEVELS FOR MONITORING GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS

被引：0
|
作者：
THOMPSON, S
WAREHAM, M
PEARSON, ADJ
SVILAND, L
TURNER, GA
机构：
[1] MED SCH NEWCASTLE UPON TYNE,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
[2] MED SCH NEWCASTLE UPON TYNE,DEPT CHILD HLTH,NEWCASTLE TYNE NE2 4HH,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [41] PREVENTION OF GRAFT-VERSUS-HOST DISEASE BY PEPTIDES WITH HIGH BINDING-AFFINITY FOR MHC CLASS-II MOLECULES
    SCHLEGEL, PG
    TRAN, NP
    FERNANDEZ, LP
    AHARONI, R
    BLUME, KG
    CHAO, NJ
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1095 - 1095
  • [42] USE OF CYCLOSPORINE FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GLUCKMAN, E
    DEVERGIE, A
    LOKIEC, F
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) : 461 - 469
  • [43] SERUM CARNITINE LEVELS IN BONE-MARROW TRANSPLANT RECIPIENTS
    KIRVELA, O
    ANTILA, H
    HEINONEN, O
    TOIVANEN, A
    CLINICAL NUTRITION, 1990, 9 (06) : 337 - 340
  • [44] PROLACTIN - A POSSIBLE MEDIATOR OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HUMANS
    HINTERBERGERFISCHER, M
    KIER, P
    SPONA, J
    SEBESTA, C
    TIEFENGRABER, E
    HABERTHEUER, KH
    RUCKSER, R
    SCHMID, A
    KALHS, P
    LECHNER, K
    HINTERBERGER, W
    BONE MARROW TRANSPLANTATION, 1994, 14 (03) : 403 - 406
  • [45] DIFFERENTIATION OF PRESUMED SEPSIS FROM ACUTE GRAFT-VERSUS-HOST DISEASE BY C-REACTIVE PROTEIN AND SERUM TOTAL IGE IN BONE-MARROW TRANSPLANT RECIPIENTS
    SAARINEN, UM
    STRANDJORD, SE
    WARKENTIN, PI
    CHEUNG, NKV
    LAZARUS, HM
    COCCIA, PF
    TRANSPLANTATION, 1987, 44 (04) : 540 - 546
  • [46] ACUTE GRAFT VERSUS HOST-DISEASE IN RECIPIENTS OF SYNGENEIC BONE-MARROW
    BELANGER, R
    TUTSCHKA, P
    BESCHORNER, W
    SANTOS, G
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 49 - 49
  • [47] EPITHELIAL CLASS-II ANTIGEN EXPRESSION IN CUTANEOUS GRAFT-VERSUS-HOST DISEASE
    BESCHORNER, WE
    FARMER, ER
    SARAL, R
    STIRLING, WL
    SANTOS, GW
    TRANSPLANTATION, 1987, 44 (02) : 237 - 243
  • [48] Graft-versus-host disease of the kidney in patients with allogenic bone marrow transplant
    Fraile, P.
    Vazquez, L.
    Garcia-Cosmes, P.
    Rivero, K.
    Lucas, C.
    Miguel, J. San
    Tabernero, J. M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S446 - S446
  • [49] Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant
    Vogelsang, GB
    Lee, L
    Bensen-Kennedy, DM
    ANNUAL REVIEW OF MEDICINE-SELECTED TOPICS IN THE CLINICAL SCIENCES, 2003, 54 : 29 - 52
  • [50] Autologous graft-versus-host disease in a porcine bone marrow transplant model
    Kunisaki, SM
    Haller, GW
    Shimizu, A
    Kitamura, H
    Colvin, RB
    Sachs, DH
    TRANSPLANTATION, 2002, 74 (04) : 465 - 471
12345